HSPA5 and gastric cancer: To reduce unfavorable side effects of anti-GRP78 antibodies, a human monoclonal IgM antibody (SAM-6) derived from a gastric cancer patient was tested which is recognizing a cancer-specific GRP78–O-linked carbohydrate moiety [109].